Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between Iodotope and Viekira Pak

Results for the following 2 drugs:
Iodotope (sodium iodide-i-131)
Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir)

Interactions between your drugs

There were no interactions found in our database between Iodotope and Viekira Pak - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Iodotope

A total of 463 drugs are known to interact with Iodotope.

Viekira Pak

A total of 896 drugs are known to interact with Viekira Pak.

Drug and food interactions

Moderate

sodium iodide I-131 food

Applies to: Iodotope (sodium iodide-i-131)

Iodine may interfere with the uptake of sodium iodide I-131 by the thyroid . A diet low in iodine and iodinated salt is recommended before starting therapy with sodium iodide I-131.

Switch to professional interaction data

Moderate

ritonavir food

Applies to: Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)

Ritonavir should be taken with food to lessen gastrointestinal side effects. It is important that you take this medication exactly as prescribed by your doctor. Do not change your treatment or stop treatment without first talking to your doctor.

Switch to professional interaction data

Moderate

paritaprevir food

Applies to: Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)

Food significantly increases the absorption of paritaprevir. You should take each dose of paritaprevir with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide